Trugen Neurosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.00 M
as on 11-12-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 11-12-2024
- Revenue 0.74%
(FY 2016)
- Profit 45.71%
(FY 2016)
- Ebitda -1.52%
(FY 2016)
- Net Worth 36.73%
(FY 2016)
- Total Assets 29.63%
(FY 2016)
About Trugen Neurosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.00 M.
Monika Garg and Vivek Garg serve as directors at the Company.
- CIN/LLPIN
U74140DL2010PTC202256
- Company No.
202256
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Trugen Neurosciences Private Limited offer?
Trugen Neurosciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, API (Active Pharmaceutical Ingredients), Montelukast Sodium Powder, Antibacterial Drugs, Ofloxacin Ornidazole Tablets, Cardiovascular Drugs & Medication, Antianginal Drugs, Blood Pressure Medicine, Telmisartan Tablets.
Who are the key members and board of directors at Trugen Neurosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monika Garg  | Whole-Time Director | 04-May-2010 | Current |
| Vivek Garg | Whole-Time Director | 04-May-2010 | Current |
Financial Performance of Trugen Neurosciences.
Trugen Neurosciences Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 0.74% increase. The company also saw a substantial improvement in profitability, with a 45.71% increase in profit. The company's net worth Soared by an impressive increase of 36.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trugen Neurosciences?
In 2017, Trugen Neurosciences had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trugen Pharmaceuticals Private LimitedActive 19 years 5 monthsMonika Garg and Vivek Garg are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 05 Jan 2012 | ₹5.00 M | Open |
How Many Employees Work at Trugen Neurosciences?
Trugen Neurosciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trugen Neurosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trugen Neurosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
